908 Devices (MASS) Receivables - Other (2020 - 2021)

908 Devices' (MASS) quarterly Receivables - Other came in at $110000.0 in Q3 2021, down 28.57% on a QoQ basis from $154000.0 in Q2 2021.

908 Devices (MASS) Receivables - Other (2020 - 2021) Analysis & Trends

908 Devices (MASS) has 2 years of Receivables - Other data on file, last reported at $110000.0 in Q3 2021.

On a quarterly basis, Receivables - Other changed N/A year-over-year to $110000.0 in Q3 2021; TTM through Sep 2021 was $110000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $47000.0, changed N/A from the prior year.
Receivables - Other for Q3 2021 stood at $110000.0, down from $154000.0 in the prior quarter.
Over the last five years, Receivables - Other for MASS reached as high as $154000.0 in Q2 2021 and fell as low as $47000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	908 Devices	261.78 Mn	150.04 Mn	6.88 Mn

Download Data